Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
32 hedge funds and large institutions have $18.8M invested in Alimera Sciences in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 12 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
22% less funds holding
Funds holding: 41 → 32 (-9)
41% less capital invested
Capital invested by funds: $31.7M → $18.8M (-$12.9M)
75% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$611K |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$254K |
| 3 |
AC
Armistice Capital
New York
|
+$60.6K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$52.2K |
| 5 |
RA
Royce & Associates
New York
|
+$45.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$2.24M |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$121K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$49K |
| 4 |
CPA
Columbia Pacific Advisors
Seattle,
Washington
|
-$45K |
| 5 |
SO
STRS Ohio
Columbus,
Ohio
|
-$38K |
ALIM Hedge Fund Activity: Q3 2019 in Review
32 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q3 2019, worth a combined $18.8M — down 41% from $31.7M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of ALIM and 3 opened new positions — a net loss of 9 holders — while 6 trimmed existing stakes and 7 added.
The largest buyer was Deerfield Management, adding an estimated $611K. The largest seller was Stonepine Capital Management, cutting an estimated $2.24M.
- 32 institutional investors held Alimera Sciences (ALIM) as of Q3 2019, down from 41 in Q2 2019.
- Funds reported $18.8M of Alimera Sciences stock for Q3 2019, down 41% quarter-over-quarter.
- 3 funds opened new Alimera Sciences positions in Q3 2019 and 12 closed out, a net change of -9 holders.
- The largest Alimera Sciences buyer in Q3 2019 was Deerfield Management, an estimated $611K added.
- The largest Alimera Sciences seller in Q3 2019 was Stonepine Capital Management, an estimated $2.24M sold.
Based on aggregated 13F filings for Q3 2019.